February 2025 - NetworkNewsWire

FridayFeb 28, 2025 12:20 pm

Forschungszentrum Jülich Becomes First High-Performance Computing Center to Own a D-Wave Quantum Inc. (NYSE: QBTS) Advantage System

Forschungszentrum Jülich scientists have already leveraged D-Wave's technology for research on protein folding, electron interactions and quantum physics. The Advantage™ system features over 5,000 qubits and 15-way connectivity, advancing quantum optimization research. The quantum system will be linked to JUPITER, Europe’s first exascale supercomputer, potentially enabling novel computational applications. The system will be upgraded to D-Wave’s next-generation Advantage2™ quantum processor when available, which D-Wave expects will deliver doubled coherence time, higher qubit connectivity and 40% improvement in energy scaling. The collaboration is anticipated to take the use of quantum technology to a new level, according to Prof. Kristel Michielsen, head…

FridayFeb 28, 2025 11:00 am

Clene Inc. (NASDAQ: CLNN) Leverages APST’s NfL Database to Support FDA-Recommended Analyses for ALS Drug

Clene is partnering with APST Research GmbH to analyze neurofilament light chain (“NfL”) data for evaluating CNM-Au8® in ALS patients. APST maintains one of the largest ALS biomarker databases, with data from over 4,300 ALS patients, including clinical outcomes and biomarker tracking. The analysis will compare NfL changes in the NIH-sponsored Expanded Access Program (“EAP”) participants with historical ALS patient data to assess CNM-Au8’s potential efficacy. Clene plans to submit its statistical analysis plan to the FDA, aiming for filing of an NDA for potential accelerated approval in the second half of 2025. No significant safety concerns have been reported…

ThursdayFeb 27, 2025 10:45 am

Adageis Drives Value-Based Care Transition as Healthcare Switches from Artificial General Intelligence to Specific Use Cases

Healthcare providers are increasingly prioritizing specific, high-impact AI applications that enhance patient care and financial performance. Adageis' ProActive Care Platform leverages AI to enhance risk assessment, workflow optimization, and revenue tracking for providers. AI-driven patient monitoring and early intervention reduce hospital readmissions and improve care quality. Adageis’ Patented Risk Engine helps healthcare providers proactively address high-risk patients, improving outcomes while increasing reimbursements. Seamless integration with multiple EHR systems ensures easy adoption without disrupting provider workflows. As in other areas, artificial intelligence is making a measurable impact on healthcare, but the focus is shifting. While artificial general intelligence (“AGI”) once dominated…

ThursdayFeb 27, 2025 10:00 am

SuperCom Ltd. (NASDAQ: SPCB) Continues Expansion of National Public Safety EM Contracts

Electronic monitoring (“EM”) technology developer SuperCom has developed a full range of best-in-class technology products and accompanying services to help criminal justice agencies reduce recidivism and incarceration costs while increasing rehabilitation potential for offenders The company recently reported a new contract win, its seventh domestic violence EM project on a national level In addition to national contract expansion throughout Europe, SuperCom has reported 20 new EM contracts throughout the United States Market analysts have noted the growing call for EM products and services, with marked increased usage in North America, Latin America, and Europe in recent years, underscoring SuperCom’s continued…

WednesdayFeb 26, 2025 10:45 am

SolarBank Corp. (NASDAQ: SUUN) (Cboe CA: SUNN) (FSE: GY2), Viridi Partner on Buffalo, NY Solar and Battery Project

SolarBank and Viridi are collaborating on a 3.06 MW solar and 1.2 MWh battery energy storage system in Buffalo, New York, repurposing a closed landfill, converting unused land into a source of clean energy. Pending approvals and financing, SolarBank is set to begin construction, while Viridi will provide the battery storage system. Viridi's battery systems include integrated fire suppression and anti-propagation technology to enhance safety. Once operational, the project will function under a community solar model, where residents can subscribe to the project, earning credits on their electricity bills without installing personal solar panels. Disseminated on behalf of SolarBank Corporation…

WednesdayFeb 26, 2025 10:00 am

Brera Holdings PLC (NASDAQ: BREA) Seen as a Rare Purchase Opportunity Based Upon Estimated Value of Single Key Player for Serie B Club Juve Stabia

Brera Holdings, an Ireland-based, international holding company with a global portfolio of men’s and women’s sports clubs, remains on track to acquire a 52% stake in Italian Serie B soccer club SS Juve Stabia Its investments are paying off, with Andrea Adorante, a star forward on the team, now having an estimated purchase value of close to €6-7 million, projected to climb to €8-10 million should he continue at his current goal-scoring pace Adorante has scored 12 goals with 2 assists so far in the current football season and could end up with 18 at that pace, winning fans and…

TuesdayFeb 25, 2025 11:30 am

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Drives Growth with Strengthened Financial Position and Cutting-Edge Research

One of the most significant challenges facing biotechnology companies is securing adequate funding to sustain research and development efforts. Calidi’s improved financial footing reassures investors and allows the company to focus on achieving key milestones in its research pipeline. The company has been selected to present new data on its RTNova systemic virotherapy platform at the prestigious AACR annual meeting in April 2025. Calidi Biotherapeutics (NYSE American: CLDI), a clinical-stage biotechnology company, is making significant strides in the field of cancer immunotherapy. Known for its innovative approach to antitumor virotherapies, Calidi is focused on harnessing the power of its patented…

TuesdayFeb 25, 2025 10:45 am

How Adageis Simplifies Value-Based Care, Boosting Revenue for Healthcare Providers

Adageis streamlines complex insurance contracts, helping providers maximize reimbursements. The company’s AI-driven solutions reduce administrative burden, freeing up time for patient care. Seamless integration with nearly 100 EHR systems ensures a smooth transition to value-based care models. The company’s fintech approach enhances financial performance, with providers seeing up to $75,000 in additional revenue. Adageis projects significant growth, expecting to cover 580,000 patient lives by mid-2025. Healthcare is shifting toward value-based care, where providers are reimbursed for patient outcomes rather than the number of procedures performed. While the model promises higher-quality care at lower costs, it also introduces complex reimbursement structures…

TuesdayFeb 25, 2025 10:00 am

East Coast Cannabis Industry Gets Ready for the New England Cannabis Convention in Boston

Traders, dealers, businesses, and enthusiasts of the cannabis industry are invited to attend the New England Cannabis Convention in Boston from March 21 to March 22, 2025. Operating since 2015, NECANN events are referred to as “MJBizCon East.” The second largest B2B event in the U.S., NECANN witnesses thousands of attendees, with the largest gathering of licensed operators, exhibitors, buyers, and leaders, for the East Coast cannabis market. These events are considered the home base for the Northeast cannabis industry. The Boston NECANN Convention 2025 will also host the prize-giving ceremony for the Boston NECANN Cup winners on March 22,…

MondayFeb 24, 2025 1:00 pm

Calidi Biotherapeutics Inc. (NYSE American: CLDI) Sees Growth, Potential in Oncology Drug Development, a Critical Frontier in Cancer Treatment

According to the American Cancer Society, cancer is the second leading cause of death globally. Oncology drugs are a cornerstone of modern cancer treatment. Calidi Biotherapeutics is a cutting-edge biotechnology company dedicated to developing innovative cancer treatments. Cancer continues to be one of the most significant health challenges of our time, with its global impact growing every year. The increasing number of cancer diagnoses and related deaths underscores the urgent need for more effective treatments, including advanced oncology drugs. Companies such as Calidi Biotherapeutics (NYSE American: CLDI) are at the forefront of research and development, offering hope for millions of…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

Month: February 2025